KFKata Dorina Fügedi

Kata Dorina Fügedi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kata Dorina Fügedi has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Csaba Tóth

    Teaching Hospital Markusovszky, University of Pécs, H-9700 Szombathely, Hungary

    1 shared publication
  • Domonkos Pál

    MTA‐TTK Lendület (Momentum) Glycan Biomarker Research Group Institute of Organic Chemistry HUN‐REN Research Centre for Natural Sciences Budapest Hungary

    1 shared publication
  • Dániel Szabó

    MS Proteomics Research Group, HUN-REN Research Centre for Natural Sciences, 1117 Budapest, Hungary

    1 shared publication
  • Dávid Papp

    MTA-ELTE Lendület (Momentum) Ion Mobility Mass Spectrometry Research Group and Department of Analytical Chemistry, Institute of Chemistry, ELTE Eötvös Loránd University, Pázmány Péter sétány 1/A, H-1117 Budapest, Hungary

    1 shared publication
  • Gitta Schlosser

    MTA-ELTE Lendület (Momentum) Ion Mobility Mass Spectrometry Research Group and Department of Analytical Chemistry, Institute of Chemistry, ELTE Eötvös Loránd University, Pázmány Péter sétány 1/A, H-1117 Budapest, Hungary

    1 shared publication
  • Gábor Tóth

    Department of Chemistry for Life Science Uppsala University Uppsala Sweden

    1 shared publication

Latest Publications

  • Open Access

    Compositional Analysis of Glycosaminoglycans in Different Lung Cancer Types—A Pilot Study

    by Domonkos Pál, Gábor Tóth, Simon Sugár, Kata Dorina Fügedi, Dániel Szabó, Ilona Kovalszky, Dávid Papp, Gitta Schlosser, Csaba Tóth, Tamás Tornóczky, et al.

    Lung cancer is one of the most commonly diagnosed cancer types. Studying the molecular changes that occur in lung cancer is important to understand tumor formation and identify new therapeutic targets and early markers of the disease to decrease mortality. Glycosaminoglycan chains play important roles in various signaling events in the tumor microenvironment. Therefore, we have determined the quantity and sulfation characteristics of chondroitin sulfate and heparan sulfate in formalin-fixed paraffin-embedded human lung tissue samples belonging to different lung cancer types as well as tumor adjacent normal areas. Glycosaminoglycan disaccharide analysis was performed using HPLC-MS following on-surface lyase digestion. Significant changes were identified predominantly in the case of chondroitin sulfate; for example, the total amount was higher in tumor tissue compared to the adjacent normal tissue. We also observed differences in the degree of sulfation and relative proportions of individual chondroitin sulfate disaccharides between lung cancer types and adjacent normal tissue. Furthermore, the differences in the 6-O-/4-O-sulfation ratio of chondroitin sulfate were different between the lung cancer types. Our pilot study revealed that further investigation of the role of chondroitin sulfate chains and enzymes involved in their biosynthesis is an important aspect of lung cancer research.